APC
TMO icon

Aspire Private Capital’s Thermo Fisher Scientific TMO Stock Holding History

Aspire Private Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13
Closed -$8.07K – 583
2024
Q3 		$8.07K Hold
13
– – ﹤0.01% 413
2024
Q2 		$7.21K Hold
13
– – ﹤0.01% 426
2024
Q1 		$7.57K Hold
13
– – ﹤0.01% 434
2023
Q4 		$6.92K Sell
13
-24
-65% -$11.6K ﹤0.01% 435
2023
Q3 		$18.7K Buy
37
+14
+61% +$7.46K 0.01% 320
2023
Q2 		$12K Buy
23
+10
+77% +$5.4K ﹤0.01% 358
2023
Q1 		$7.5K Hold
13
– – ﹤0.01% 400
2022
Q4 		$7.17K Sell
13
-9
-41% -$4.77K ﹤0.01% 392
2022
Q3 		$11K Hold
22
– – ﹤0.01% 338
2022
Q2 		$12K Hold
22
– – ﹤0.01% 332
2022
Q1 		$13K Sell
22
-10
-31% -$5.74K ﹤0.01% 326
2021
Q4 		$21K Buy
32
+9
+39% +$5.62K 0.01% 283
2021
Q3 		$13K Hold
23
– – ﹤0.01% 295
2021
Q2 		$12K Buy
23
+10
+77% +$4.72K ﹤0.01% 312
2021
Q1 		$6K Sell
13
-331
-96% -$158K ﹤0.01% 371
2020
Q4 		$160K Buy
344
+9
+3% +$4.22K 0.06% 137
2020
Q3 		$148K Buy
335
+43
+15% +$17.8K 0.06% 126
2020
Q2 		$106K Buy
292
+23
+9% +$7.71K 0.05% 129
2020
Q1 		$76K Sell
269
-128
-32% -$40.4K 0.04% 136
2019
Q4 		$129K Buy
397
+6
+2% +$1.82K 0.06% 138
2019
Q3 		$114K Buy
391
+32
+9% +$9.16K 0.05% 142
2019
Q2 		$105K Buy
359
+351
+4,388% +$96.7K 0.05% 148
2019
Q1 		$2K Hold
8
– – ﹤0.01% 457
2018
Q4 		$2K Buy
+8
New +$1.88K ﹤0.01% 430

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Aspire Private Capital's TMO Position: Q4 2024 in Review

Aspire Private Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 13 shares — an estimated $8.07K sold.

Aspire Private Capital first reported a position in TMO in Q4 2018 and held it in 24 quarters. The position peaked at $160K in Q4 2020. 2,624 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Aspire Private Capital reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 13 Thermo Fisher Scientific shares in Q4 2024, an estimated $8.07K.
  • Aspire Private Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 24 quarters.
  • Aspire Private Capital's Thermo Fisher Scientific position peaked at $160K in Q4 2020.
  • 2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.